期刊文献+

DNA甲基化与妇科肿瘤 被引量:4

下载PDF
导出
摘要 DNA甲基化是肿瘤抑制基因失活的第 3种机制 ,DNA甲基化造成的基因异常对肿瘤的发生及发展有着重要影响。许多肿瘤相关基因启动子区域CpG岛过甲基化与妇科肿瘤的形成密切相关 ,DNA甲基化研究将广泛应用于妇科肿瘤的分类、肿瘤的早期发现、治疗以及预测肿瘤转移复发等。
作者 洪凡真 王波
出处 《国外医学(肿瘤学分册)》 2004年第3期229-233,共5页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献24

  • 1Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression. Cancer Lett,2003, 190(2):125-133.
  • 2Heanev A P, Melmed S. New pituitary oncogenes. Endoer Relat Cancer, 2000,7 ( 1 ) ; 3-15.
  • 3Reik W, Murrell A. Genomic imprinting. Silence across the border.Nature, 2000,405 (6785) : 408-409.
  • 4Lee IT, Davidow LS, Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet, 1999,21 ( 4 ) : 400-404.
  • 5Wong YF, Chung TK, Cheung TH, et al. Methylation of p161NK4A in primary gynecologic malignancy. Cancer Lett, 1999, 136(2):231-235.
  • 6Strathdee G, Appleton K, llland M, et al. Primary ovarianearcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol,2001,158(3) : 1121-1127.
  • 7McCluskey LL, Chen C, Delgadillo E, et al. Differences in p16 gene methylation and expression in benign and malignant ovarian tumors. Gynecol Oneol, 1999, 72 ( 1 ) : 87-92.
  • 8Brown I, Milner BJ, Rooney PH, et al. Inactivation of the p16INK4A gene by methylation is not a frequent event in sporadic ovarian carcinoma. Oneol Rep,2001, 8(6) : 1359-1362.
  • 9Yoon JH, Dammann R, Pfeifer GP. Hypennethylatlon of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas.Int J Cancer, 2001, 94(2) :212-217.
  • 10Strathdee G, MacKean Mj, Illand M, et al. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene, 1999, 18 ( 14 ) : 2335-2341.

同被引文献38

  • 1Watanabe T,Nakamura M,Yonekawa Y,et al.Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas [J].Acta Neuropathol(Berl) ,2001,101 (3) :185 - 189.
  • 2Bird AP.DNA methylation de novo[J].Science,1999,286 (5448):2287- 2288.
  • 3Liggett WH Jr,Sidransky D.Role of the p16 tumor suppressor gene in cancer[J].J Clin Oncol,1998,16(3):1197 - 1206.
  • 4Rocco JW,Sidransky D.p16 (MTS-1/CDKN2/INK4a) in cancer progression[J].Exp Cell Res,2001,264(1) :42 - 55.
  • 5Jin X,Nguyen D,Zhang WW,et al.Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector[J].Cancer Res,1995,55:3250 - 3253.
  • 6Nephew KP,Huang TH.Epigenetic gene silencing in cancer initiation and progression [J].Cancer Lett,2003,190 (20):125 -133.
  • 7Gonzalez-Zulueta M,Bender CM,Yang AS,et al.Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing[J].Cancer Res,1995,55(20) :4531 - 4515.
  • 8Narayan G,Arias-Pulido H,Nandula SV,et al.Promoter hypermethylation of p16INK4A:disruption of Fanconi AnemiaBRCA pathway in cervical cancer[J].Cancer Res,2004,64(9):2994 - 2997.
  • 9vander Heijden MS,Yeo CJ,Hruban RH,et al.Fanconianemia gene mutations in young-onset pancreatic cancer[J].Cancer Res,2003,63 (10) :2585 - 2588.
  • 10SambrookJ FritschEF ManiatisT eds.金冬雁 黎孟枫 译.分子克隆实验指南.第2版[M].北京:科学出版社,1996.463-468.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部